Supplier log in
Bortezomib RFP
Details
|
Tender Closed
|
|
| RFx ID : | 17320823 |
| Tender Name : | Bortezomib RFP |
| Reference # : | A869347 |
| Open Date : | Wednesday, 16 March 2016 2:00 PM (Pacific/Auckland UTC+13:00) |
| Close Date : | Wednesday, 13 April 2016 5:00 PM (Pacific/Auckland UTC+12:00) |
| Tender Type : | Request for Proposals (RFP) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Exemption Reason : | None |
| Required Pre-qualifications : | None |
| Contact : |
Chloe Dimock procurement@pharmac.govt.nz |
| Alternate Physical Delivery Address : | |
| Alternate Physical Fax Number : | |
| Agency Address : | |
REQUEST FOR PROPOSALS – SUPPLY OF BORTEZOMIB
PHARMAC invites proposals for the supply of bortezomib in New Zealand.
This request for proposals (RFP) letter incorporates the following schedules:
· Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
· Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
· Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
· Schedule 4 contains the RFP form in which you are to provide details of your proposal.
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Services (GETS) no later than 5.00 p.m. on 13 April 2016.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz) or alternatively contact Chloë Dimock at PHARMAC by email procurement@pharmac.govt.nz.
We look forward to receiving your proposal.
This tender has been awarded to:
- Janssen-Cilag Pty Ltd
Further Award Information:
PHARMAC is pleased to announce the decision to award Hospital Supply Status (HSS) from 1 July 2016 until 30 June 2019 for bortezomib in DHB hospitals to Janssen-Cilag’s brand of bortezomib (Velcade) inj 3.5 mg vial with a 1% discretionary variance (DV) limit.
For full details please refer to our website: http://www.pharmac.govt.nz/news/notification-2016-06-10-bortezomib/
Award Date: Thursday, 23 June 2016 (Pacific/Auckland UTC+12:00)
Date RFx was completed/updated: Wednesday, 13 April 2016 5:00 PM (Pacific/Auckland UTC+12:00)
